On January 22, 2020 David Koos resigned as Chairman of the Board of Directors, Chief Executive Officer of and from any and all offices held at Regen Biopharma, Inc. (the "Company") as of 1 pm Pacific Standard Time on January 22, 2020 ("Effective Date and Time"). As of the Effective Date and Time Todd S. Caven, the Company's Chief Financial Officer and a member of the Board of Directors of the Company, shall be the Company's sole officer and member of the Company's Board of Directors.